Peptide · Vial
BPC 157
$8910mg
An experimental peptide best known for early research into tissue repair, tendon injury and wound response.
EternaGen / Research use onlyPeptide · Research use only
Tirzepatide
From CA$139CAD
A dual GIP and GLP-1 receptor agonist studied in metabolic research.
Available to approved purchasers
Select strength
1
Documentation review pending Fulfilled in Canada Research use only
Can’t find the right record?Send support the product name or batch code.
Contact supportProduct information
Tirzepatide, clearly explained.
A dual GIP and GLP-1 receptor agonist studied in metabolic research.
Overview
Tirzepatide is the active ingredient in prescription medicines approved in Canada under specific conditions. Clinical trial results for those approved products cannot be applied to a separately sourced research material.
- Format
- Vial
- Available strengths
- 10mg · 20mg · 30mg
- Documentation
- Source review pending
Specifications
Product details
- Storage and handling
- Store lyophilized material according to the conditions on the batch record. Protect from light and moisture.
Batch documentationSource review pending
Not yet publishedSupplier-origin documentation will be published only after EternaGen verifies the source and record details.
Related products
Continue comparing.
Peptide · Vial
GHK-CU
From CA$54.9950mg100mg
A naturally occurring copper-binding peptide explored in skin, collagen and wound-healing research.
Peptide · Pen
MOTS-c
From CA$6410mg20mg
A peptide made inside mitochondria and studied for its connection to energy, exercise and metabolic stress.